1921
Volume 82, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Many West Nile (WN) virus isolates associated with significant outbreaks possess a glycosylation site on the envelope (E) protein. E-protein glycosylated variants of New York (NY) strains of WN virus are more neuroinvasive in mice than the non-glycosylated variants. To determine how E protein glycosylation affects the interactions between WN virus and avian hosts, we inoculated young chicks with NY strains of WN virus containing either glycosylated or non-glycosylated variants of the E protein. The glycosylated variants were more virulent and had higher viremic levels than the non-glycosylated variants. The glycosylation status of the variant did not affect viral multiplication and dissemination in mosquitoes . Glycosylated variants showed more heat-stable propagation than non-glycosylated variants in mammalian (BHK) and avian (QT6) cells but not in mosquito (C6/36) cells. Thus, E-protein glycosylation may be a requirement for efficient transmission of WN virus from avian hosts to mosquito vectors.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2010.09-0262
2010-04-05
2020-05-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/4/696.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0262&mimeType=html&fmt=ahah

References

  1. Takasaki T, 2007. West Nile fever/encephalitis. Uirusu 57: 199205.[Crossref]
    [Google Scholar]
  2. Hamman MH, Delphine HC, Winston HP, 1965. Antigenic variation of West Nile virus in relation to geography. Am J Epidemiol 82: 4055.[Crossref]
    [Google Scholar]
  3. Hubálek Z, Halouzka J, 1999. West Nile fever—a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis 5: 643650.[Crossref]
    [Google Scholar]
  4. Anderson JF, Vossbrinck CR, Andreadis TG, Iton A, Beckwith WH 3rd, Mayo DR, 2001. A phylogenetic approach to following West Nile virus in Connecticut. Proc Natl Acad Sci USA 98: 1288512889.[Crossref]
    [Google Scholar]
  5. Garmendia AE, Van Kruiningen HJ, French RA, 2001. The West Nile virus: its recent emergence in North America. Microbes Infect 3: 223229.[Crossref]
    [Google Scholar]
  6. Marfin AA, Gubler DJ, 2001. West Nile encephalitis: an emerging disease in the United States. Clin Infect Dis 33: 17131719.[Crossref]
    [Google Scholar]
  7. Brault AC, Langevin SA, Bowen RA, Panella NA, Biggerstaff BJ, Miller BR, Komar N, 2004. Differential virulence of West Nile strains for American crows. Emerg Infect Dis 10: 21612168.[Crossref]
    [Google Scholar]
  8. Brault AC, Huang CY, Langevin SA, Kinney RM, Bowen RA, Ramey WN, Panella NA, Holmes EC, Powers AM, Miller BR, 2007. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet 39: 11621166.[Crossref]
    [Google Scholar]
  9. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, Davis B, Bowen R, Bunning M, 2003. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 9: 311322.[Crossref]
    [Google Scholar]
  10. Seligman SJ, Bucher DJ, 2003. The importance of being outer: consequences of the distinction between the outer and inner surfaces of flavivirus glycoprotein E. Trends Microbiol 11: 108110.[Crossref]
    [Google Scholar]
  11. Chambers TJ, Hahn CS, Galler R, Rice CM, 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44: 649688.[Crossref]
    [Google Scholar]
  12. Shirato K, Miyoshi H, Goto A, Ako Y, Ueki T, Kariwa H, Takashima I, 2004. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J Gen Virol 85: 36373645.[Crossref]
    [Google Scholar]
  13. Goto A, Yoshii K, Obara M, Ueki T, Mizutani T, Kariwa H, Takashima I, 2005. Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. Vaccine 23: 30433052.[Crossref]
    [Google Scholar]
  14. Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD, 2005. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol 79: 83398347.[Crossref]
    [Google Scholar]
  15. Maeda A, Murata R, Akiyama M, Takashima I, Kariwa H, Watanabe T, Kurane I, Maeda J, 2009. A PCR-based protocol for generating of a recombinant West Nile virus. Virus Res 144: 3543.[Crossref]
    [Google Scholar]
  16. Peiris JS, Porterfield JS, Roehrig JT, 1982. Monoclonal antibodies against the flavivirus West Nile. J Gen Virol 58: 283289.[Crossref]
    [Google Scholar]
  17. Komoro K, Hayasaka D, Mizutani T, Kariwa H, Takashima I, 2000. Characterization of monoclonal antibodies against Hokkaido strain tick-borne encephalitis virus. Microbiol Immunol 44: 533536.[Crossref]
    [Google Scholar]
  18. Beasley DW, Davis CT, Estrada-Franco J, Navarro-Lopez R, Campomanes-Cortes A, Tesh RB, Weaver SC, Barrett AD, 2004. Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis 10: 22212224.[Crossref]
    [Google Scholar]
  19. Halevy M, Akov Y, Ben-Nathan D, Kobiler D, Lachmi B, Lustig S, 1994. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 137: 355370.[Crossref]
    [Google Scholar]
  20. Moudy RM, Zhang B, Shi PY, Kramer LD, 2009. West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology 387: 222228.[Crossref]
    [Google Scholar]
  21. Gibbs SE, Ellis AE, Mead DG, Allison AB, Moulton JK, Howerth EW, Stallknecht DE, 2005. West Nile virus detection in the organs of naturally infected blue jays (Cyanocitta cristata). J Wildl Dis 41: 354362.[Crossref]
    [Google Scholar]
  22. Kasturi L, Eshleman JR, Wunner WH, Shakin-Eshleman SH, 1995. The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J Biol Chem 270: 1475614761.[Crossref]
    [Google Scholar]
  23. Wicker JA, Whiteman MC, Beasley DW, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett AD, 2006. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Virology 349: 245253.[Crossref]
    [Google Scholar]
  24. Kinney RM, Huang CY, Whiteman MC, Bowen RA, Langevin SA, Miller BR, Brault AC, 2006. Avian virulence and thermostable replication of the North American strain of West Nile virus. J Gen Virol 87: 36113622.[Crossref]
    [Google Scholar]
  25. Jia Y, Moudy RM, Dupuis AP 2nd, Ngo KA, Maffei JG, Jerzak GV, Franke MA, Kauffman EB, Kramer LD, 2007. Characterization of a small plaque variant of West Nile virus isolated in New York in 2000. Virology 367: 339347.[Crossref]
    [Google Scholar]
  26. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC, 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375: 291298.[Crossref]
    [Google Scholar]
  27. Modis Y, Ogata S, Clements D, Harrison SC, 2003. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 100: 69866991.[Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0262
Loading
/content/journals/10.4269/ajtmh.2010.09-0262
Loading

Data & Media loading...

  • Received : 14 May 2009
  • Accepted : 01 Dec 2009
  • Published online : 05 Apr 2010
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error